Most bought healthcare stocks in Q1 2024
See which Healthcare stocks institutional investors increased the most in Q1 2024, measured as net growth in reported share positions from Q4 2023 into Q1 2024. Notable additions at the top of this list include STANDARD BIOTOOLS INC (LAB), HALEON PLC-ADR (HLN), CVS HEALTH CORP (CVS), GE HEALTHCARE TECHNOLOGY (GEHC). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC | 71,907,868 | $194.29M | 2 | 1 | 0 | 0 | 3 |
| HLN | HALEON PLC-ADR | 64,777,471 | $592.11M | 0 | 2 | 4 | 0 | 6 |
| CVS | CVS HEALTH CORP | 14,982,048 | $1.27B | 1 | 4 | 5 | 2 | 11 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 4,980,550 | $743.27M | 1 | 1 | 3 | 0 | 9 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 4,910,354 | $778.66M | 0 | 3 | 5 | 0 | 9 |
| AVTR | AVANTOR INC | 4,679,511 | $313.93M | 1 | 1 | 2 | 1 | 5 |
| ZTS | ZOETIS INC | 4,658,548 | $409.99M | 2 | 4 | 4 | 0 | 11 |
| BMY | BRISTOL-MYERS SQUIBB CO | 4,086,961 | $423.20M | 1 | 5 | 3 | 1 | 10 |
| RXRX | RECURSION PHARMACEUTICALS-A | 3,933,274 | $41.49M | 0 | 1 | 0 | 0 | 1 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,922,400 | $55.00M | 1 | 0 | 1 | 0 | 2 |
| ABT | ABBOTT LABORATORIES | 3,347,377 | $350.33M | 1 | 2 | 4 | 0 | 11 |
| ABSI | ABSCI CORP | 3,276,794 | $18.61M | 1 | 0 | 1 | 0 | 2 |
| PRME | PRIME MEDICINE INC | 3,164,192 | $14.15M | 0 | 2 | 0 | 0 | 2 |
| LFST | LIFESTANCE HEALTH GROUP INC | 3,018,143 | $4.40M | 1 | 1 | 0 | 0 | 2 |
| DOCS | DOXIMITY INC-CLASS A | 2,680,892 | $63.49M | 0 | 2 | 1 | 1 | 3 |
| BAYRY | BAYER AG-SPONSORED ADR | 2,386,640 | $17.16M | 0 | 1 | 0 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 2,343,170 | $40.40M | 1 | 1 | 1 | 0 | 3 |
| TXG | 10X GENOMICS INC-CLASS A | 2,294,925 | $9.68M | 1 | 1 | 0 | 0 | 2 |
| IMVT | IMMUNOVANT INC | 2,130,572 | $58.46M | 1 | 1 | 0 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,063,458 | -$2.11M | 1 | 1 | 1 | 0 | 3 |
| OGN | ORGANON & CO | 1,506,773 | $48.96M | 1 | 2 | 0 | 0 | 3 |
| OPK | OPKO HEALTH INC | 1,378,196 | $1.65K | 1 | 0 | 0 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | 1,370,100 | -$598 | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 1,265,640 | $523.86M | 3 | 1 | 2 | 0 | 6 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | 1,052,728 | $21.20M | 2 | 0 | 0 | 0 | 2 |
| ADMA | ADMA BIOLOGICS INC | 949,100 | $8.46K | 0 | 1 | 0 | 0 | 1 |
| MRNA | MODERNA INC | 888,903 | $87.41M | 1 | 3 | 0 | 0 | 4 |
| VXRT | VAXART INC | 881,800 | $1.18K | 0 | 1 | 0 | 0 | 1 |
| ACB | AURORA CANNABIS INC | 879,670 | $3.86K | 1 | 0 | 0 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 878,800 | $10.17K | 0 | 1 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 853,481 | $18.24M | 1 | 1 | 1 | 0 | 4 |
| IKNA | IKENA ONCOLOGY INC | 776,600 | $1.10K | 1 | 0 | 0 | 0 | 1 |
| VREX | VAREX IMAGING CORP | 769,124 | $10.71M | 0 | 2 | 1 | 0 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | 696,400 | $1.43K | 0 | 1 | 0 | 0 | 1 |
| IMUX | IMMUNIC INC | 672,465 | $874 | 0 | 1 | 0 | 0 | 1 |
| CARA | CARA THERAPEUTICS INC | 638,406 | $306.01K | 0 | 2 | 0 | 0 | 2 |
| PGNY | PROGYNY INC | 629,537 | $21.57M | 1 | 2 | 0 | 0 | 3 |
| CERS | CERUS CORP | 626,070 | -$4.45M | 0 | 1 | 1 | 0 | 2 |
| FTRE | FORTREA HOLDINGS INC | 623,220 | $6.47M | 1 | 2 | 0 | 2 | 4 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 598,903 | -$1.66M | 0 | 2 | 0 | 0 | 2 |
| VNDA | VANDA PHARMACEUTICALS INC | 594,500 | $2.04K | 0 | 1 | 0 | 0 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 576,100 | $20.51K | 0 | 1 | 0 | 0 | 1 |
| MRSN | MERSANA THERAPEUTICS INC | 562,088 | $4.39K | 0 | 1 | 0 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | 540,628 | -$59.80K | 0 | 2 | 0 | 0 | 2 |
| HRTX | HERON THERAPEUTICS INC | 523,186 | $3.46K | 0 | 1 | 0 | 0 | 1 |
| ACHL | ACHILLES THERAPEUTICS PL-ADR | 506,764 | $813 | 0 | 1 | 0 | 0 | 1 |
| RLYB | RALLYBIO CORP | 488,100 | -$2.26M | 1 | 0 | 0 | 0 | 2 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 486,500 | $3.00K | 0 | 1 | 0 | 0 | 1 |
| NTRA | NATERA INC | 455,793 | $30.37M | 2 | 1 | 1 | 0 | 4 |
| INO | INOVIO PHARMACEUTICALS INC | 450,266 | $6.25K | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2024
What are the most bought Healthcare stocks in Q1 2024?
The most bought healthcare stocks in Q1 2024 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2024?
Among the managers we track, net additions were largest in companies such as STANDARD BIOTOOLS INC (LAB), HALEON PLC-ADR (HLN), CVS HEALTH CORP (CVS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2023).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.